Renal Cell Carcinoma — Trials

Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,621 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 375
Recruiting: 191
Ph III recruiting: 14
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (276)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06472895	A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma	not yet recruiting	Phase 1 / Phase 2	30	Peking University Cancer Hospital & InstituteOTHER	0	Jun 25, 2024	clinicaltrials
NCT06383507	A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors	not yet recruiting	Phase 1	18	Zhejiang UniversityOTHER	0	Apr 25, 2024	clinicaltrials